199 related articles for article (PubMed ID: 31338833)
21. A novel mutation, Ile289Thr, in the ALAS2 gene in a family with pyridoxine responsive sideroblastic anaemia.
Percy MJ; Cuthbert RJ; May A; McMullin MF
J Clin Pathol; 2006 Sep; 59(9):1002. PubMed ID: 16935983
[No Abstract] [Full Text] [Related]
22. Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia.
Fernández-Murray JP; Prykhozhij SV; Dufay JN; Steele SL; Gaston D; Nasrallah GK; Coombs AJ; Liwski RS; Fernandez CV; Berman JN; McMaster CR
PLoS Genet; 2016 Jan; 12(1):e1005783. PubMed ID: 26821380
[TBL] [Abstract][Full Text] [Related]
23. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia.
Brownlie A; Donovan A; Pratt SJ; Paw BH; Oates AC; Brugnara C; Witkowska HE; Sassa S; Zon LI
Nat Genet; 1998 Nov; 20(3):244-50. PubMed ID: 9806542
[TBL] [Abstract][Full Text] [Related]
24. Sideroblastic anemia, iron overload, and ALAS2 R452S in African-American males: phenotype and genotype features of five unrelated patients.
Lee PL; Reid TJ; Bottomley SS; Barton JC
Am J Hematol; 2011 Sep; 86(9):787-9. PubMed ID: 21800356
[No Abstract] [Full Text] [Related]
25. Multi-organ iron overload in an African-American man with ALAS2 R452S and SLC40A1 R561G.
Sussman NL; Lee PL; Dries AM; Schwartz MR; Barton JC
Acta Haematol; 2008; 120(3):168-73. PubMed ID: 19066423
[TBL] [Abstract][Full Text] [Related]
26. Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation.
Cazzola M; May A; Bergamaschi G; Cerani P; Ferrillo S; Bishop DF
Blood; 2002 Dec; 100(12):4236-8. PubMed ID: 12393718
[TBL] [Abstract][Full Text] [Related]
27. A Novel
Lee JS; Gu J; Yoo HJ; Koh Y; Kim HK
Ann Clin Lab Sci; 2017 May; 47(3):319-322. PubMed ID: 28667034
[TBL] [Abstract][Full Text] [Related]
28. A Novel g.55040074delT in ALAS2 Gene Resulting in a Monomeric Protein and Severe Sideroblastic Anemia Phenotype.
Bhatia P; Singh A; Hedge A
J Pediatr Hematol Oncol; 2017 Aug; 39(6):463-465. PubMed ID: 28731922
[TBL] [Abstract][Full Text] [Related]
29. [Molecular pathophysiology of sideroblastic anemia].
Fujiwara T
Rinsho Ketsueki; 2018; 59(10):1979-1987. PubMed ID: 30305500
[TBL] [Abstract][Full Text] [Related]
30. Novel mutations in the ALAS2 gene from patients with X-linked sideroblastic anemia.
Li J; Chen L; Lin Y; Ru K
Int J Lab Hematol; 2020 Aug; 42(4):e160-e163. PubMed ID: 32297424
[No Abstract] [Full Text] [Related]
31. A novel hemizygous I418S mutation in the ALAS2 gene in a young Korean man with X-linked sideroblastic anemia.
Moon SY; Jun IJ; Kim JE; Lee SJ; Kim HK; Yoon SS
Ann Lab Med; 2014 Mar; 34(2):159-62. PubMed ID: 24624355
[No Abstract] [Full Text] [Related]
32. Mutation analysis of Chinese sporadic congenital sideroblastic anemia by targeted capture sequencing.
An W; Zhang J; Chang L; Zhang Y; Wan Y; Ren Y; Niu D; Wu J; Zhu X; Guo Y
J Hematol Oncol; 2015 May; 8():55. PubMed ID: 25985931
[TBL] [Abstract][Full Text] [Related]
33. Different haematological picture of congenital sideroblastic anaemia in a hemizygote and a heterozygote.
Aguiar E; Freitas MI; Barbot J
Br J Haematol; 2014 Aug; 166(4):469. PubMed ID: 24862439
[No Abstract] [Full Text] [Related]
34. Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors.
Giannelou A; Wang H; Zhou Q; Park YH; Abu-Asab MS; Ylaya K; Stone DL; Sediva A; Sleiman R; Sramkova L; Bhatla D; Serti E; Tsai WL; Yang D; Bishop K; Carrington B; Pei W; Deuitch N; Brooks S; Edwan JH; Joshi S; Prader S; Kaiser D; Owen WC; Sonbul AA; Zhang Y; Niemela JE; Burgess SM; Boehm M; Rehermann B; Chae J; Quezado MM; Ombrello AK; Buckley RH; Grom AA; Remmers EF; Pachlopnik JM; Su HC; Gutierrez-Cruz G; Hewitt SM; Sood R; Risma K; Calvo KR; Rosenzweig SD; Gadina M; Hafner M; Sun HW; Kastner DL; Aksentijevich I
Ann Rheum Dis; 2018 Apr; 77(4):612-619. PubMed ID: 29358286
[TBL] [Abstract][Full Text] [Related]
35. [A case report of X-linked sideroblastic anemia with novel ALAS2 gene mutation].
Bao SJ; Zhu HM; Tong Y; Hao D; Ling Y; Yuan W; Zhou Y; Sun ZQ
Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):684. PubMed ID: 31495138
[No Abstract] [Full Text] [Related]
36. Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD).
Chakraborty PK; Schmitz-Abe K; Kennedy EK; Mamady H; Naas T; Durie D; Campagna DR; Lau A; Sendamarai AK; Wiseman DH; May A; Jolles S; Connor P; Powell C; Heeney MM; Giardina PJ; Klaassen RJ; Kannengiesser C; Thuret I; Thompson AA; Marques L; Hughes S; Bonney DK; Bottomley SS; Wynn RF; Laxer RM; Minniti CP; Moppett J; Bordon V; Geraghty M; Joyce PB; Markianos K; Rudner AD; Holcik M; Fleming MD
Blood; 2014 Oct; 124(18):2867-71. PubMed ID: 25193871
[TBL] [Abstract][Full Text] [Related]
37. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
[TBL] [Abstract][Full Text] [Related]
38. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
[TBL] [Abstract][Full Text] [Related]
39. Pyridoxine-refractory congenital sideroblastic anaemia with evidence for autosomal inheritance: exclusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis.
Jardine PE; Cotter PD; Johnson SA; Fitzsimons EJ; Tyfield L; Lunt PW; Bishop DF
J Med Genet; 1994 Mar; 31(3):213-8. PubMed ID: 7912287
[TBL] [Abstract][Full Text] [Related]
40. [Successful treatment of X-linked sideroblastic anemia with ALAS2 R452H mutation using vitamin B
Kawakami T; Nakazawa H; Kawakami F; Matsuzawa S; Sudo Y; Sakai H; Nishina S; Senoo N; Senoo Y; Komatsu M; Umemura T; Yamaguchi T; Kosho T; Fujiwara T; Harigae H; Ishida F
Rinsho Ketsueki; 2018; 59(4):401-406. PubMed ID: 29743399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
